| Typicality: | 0.317 |
| Saliency: | 0.157 |
| with patient representatives | 4 | other |
| trial → be designed in → consultation | 5 |
| trial → include → consultation | 3 |
| negative | neutral | positive |
| 0.016 | 0.791 | 0.194 |
| Raw frequency | 8 |
| Normalized frequency | 0.157 |
| Modifier score | 0.500 |
| Perplexity | 360.553 |